Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Leuk Lymphoma. 2019 Jul 9;60(14):3426–3433. doi: 10.1080/10428194.2019.1639166

Fig. 1.

Fig. 1.

(A) Overall survival of patients with THRLBCL, DLBCL-NOS, and NLPHL; (B) overall survival in THRLBCL, compared with DLBCL-NOS matched by age, sex, race, stage, presence of B symptoms, extranodal site, comorbidity index, income, and type of treating hospital.